.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,316,031

« Back to Dashboard

Details for Patent: 6,316,031

Title: Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
Abstract:A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature and relative humidity elevated to a suitable level above ambient conditions until the coated dosage form attains a stabilized dissolution profile substantially unaffected by exposure to storage conditions of elevated temperature and/or elevated relative humidity.
Inventor(s): Oshlack; Benjamin (New York, NY), Pedi, Jr.; Frank (Yorktown Heights, NY), Chasin; Mark (Manalapan, NJ)
Assignee: Purdue Pharma LP (Norwalk, CT)
Filing Date:Dec 22, 1999
Application Number:09/469,478
Claims:1. A controlled release layered bead for inclusion in an oral controlled release pharmaceutical formulation comprising

an inert bead coated with an analgesic,

a barrier layer over said bead coated with said analgesic, said barrier layer comprising hydroxypropylmethylcellulose,

a controlled release layer over said barrier layer derived from an aqueous dispersion of plasticized ethylcellulose in an amount sufficient to obtain a controlled release of said analgesic when said formulation is exposed to an environmental fluid, said controlled release layered bead being cured to a temperature greater than the glass transition temperature of the plasticized ethylcellulose for at least about 24 hours.

2. The controlled release layered bead of claim 1, wherein said barrier layered bead is coated to a weight gain from about 2 to about 30% with said controlled release layer.

3. The controlled release layered bead of claim 1, further comprising a second barrier layer over said controlled release layer, said second barrier layer comprising hydroxypropylmethylcellulose.

4. The controlled release layered bead of claim 1, wherein said controlled release layer further comprises a release-modifying agent in an amount effective to modify the rate of release of said analgesic from said cured, coated bead.

5. The controlled release layered bead of claim 4, wherein said release-modifying agent is selected from the group consisting of a hydrophilic polymer, a semi-permeable polymer, an erosion-promoting polymer, an agent capable of making microporous lamina, a poreformer and mixtures of any of the foregoing.

6. The controlled release layered bead of claim 5, wherein said controlled release layer comprises from about 0.1% to about 70% of said release-modifying agent.

7. The controlled release layered bead of claim 6, wherein said release-modifying agent is selected from the group consisting of hydroxypropylmethylcellulose, lactose, metal stearates and mixtures of any of the foregoing.

8. The controlled release layered bead of claim 1, wherein a portion of the amount of said analgesic included in said bead is incorporated into an outer coating.

9. A method for preparing a controlled release layered bead for inclusion in an oral controlled release formulation of an analgesic, comprising:

coating a pharmaceutically acceptable inert bead with an analgesic;

thereafter coating said bead with a barrier layer comprising hydroxypropylmethylcellulose;

thereafter applying a controlled release layer onto said bead, said controlled release layer comprising a sufficient amount of a plasticized ethylcellulose to obtain a predetermined controlled release of said analgesic when said coated bead is exposed to an environmental fluid, said plasticized ethylcellulose being applied to said bead as an aqueous dispersion; and

curing said controlled release layered bead at a temperature greater than the glass transition temperature of the plasticized ethylcellulose for at least 24 hours.

10. The method of claim 9, further comprising coating said controlled release bead with an outer layer comprising said analgesic.

11. The method of claim 9, further comprising applying said controlled release layer onto said bead to a weight gain from about 2 to about 25%.

12. The method of claim 9, further comprising adding a release-modifying agent to said controlled release layer in an amount effective to modify the rate of release of said analgesic from said cured, coated bead.

13. The method of claim 12, wherein said release-modifying agent is selected from the group consisting of a hydrophilic polymer, a semi-permeable polymer, an erosion-promoting polymer, an agent capable of making microporous lamina, a pore-former, and mixtures of any of the foregoing.

14. The method of claim 13, wherein said controlled release layer comprises from about 0.1% to about 70% of said release-modifying agent.

15. The method of claim 14, wherein said controlled release layer comprises from about 0.1% to about 50% of said release-modifying agent.

16. The method of claim 15, wherein said controlled release layer comprises from about 0.1% to about 25% of said release-modifying agent.

17. The method of claim 12, wherein said release-modifying agent is selected from the group consisting of hydroxypropylmethylcellulose, lactose, metal stearates, and mixtures of any of the foregoing.

18. The method of claim 9, further comprising overcoating said controlled release bead with a second barrier layer comprising hydroxypropylmethylcellulose.

19. The method of claim 9, further comprising the step of overcoating said controlled release bead with an outer layer comprising said analgesic.

20. The method of claim 19, wherein said outer layer comprises hydroxypropylmethylcellulose.

21. A controlled release layered bead for inclusion in a controlled release pharmaceutical formulation, comprising a pharmaceutically acceptable inert bead coated with an analgesic, said bead coated with said analgestic being overcoated with a barrier layer comprising hydroxypropylmethylcellulose, said barrier coated bead being coated with a controlled release layer derived from an aqueous dispersion of plasticized ethylcellulose in an amount sufficient to obtain a controlled release of said analgesic when said bead is exposed to a gastrointestinal fluid, said coated bead being cured at a temperature greater than the glass transition temperature of the plasticized ethylcellulose for at least about 24 hours, to cause individual ethylcellulose particles in said coating to coalesce and to gradually slow the release of said analgesic when said bead is exposed to aqueous fluid, until an endpoint is reached at which said cured coated bead, when subjected to in-vitro dissolution, releases said analgesic in amounts which do not vary at any time point along the dissolution curve by more than about 20% of the total amount of analgesic released, when compared to the in-vitro dissolution of said coated bead prior to curing.

22. The controlled release layered bead of claim 21, wherein said cured, coated bead provides the same rate of release immediately after curing to said endpoint, and after subsequent exposure to accelerated storage conditions of one month at a temperature of 37.degree. C. and at a relative humidity of 80%.

23. The controlled release layered bead of claim 21, wherein said cured, coated bead provides the same rate of release immediately after curing to said endpoint, and after subsequent exposure to accelerated storage conditions of one month at a temperature of 40.degree. C. and at a relative humidity of 75%.

24. The controlled release layered bead of claim 21, wherein said controlled release layer is applied on said barrier coated bead to a weight gain from about 2% to about 25%.

25. The controlled release layered bead of claim 21, which includes said controlled released layer sufficient to obtain a controlled release of said analgesic when measured by the USP Paddle Method of U.S. Pharmacopeia XXII (1990) at 100 rpm at 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37.degree. C. from about 12.5% to about 42.5% (by wt) analgesic released after 1 hour, from about 25% to about 55% (by wt) analgesic released after 2 hours, from about 45% to about 75% (by wt) analgesic released after 4 hours and from about 55% to about 85% (by wt) analgesic released after 8 hours.

26. The controlled release layered bead of claim 21, wherein said controlled release layer further comprises a release-modifying agent in an amount effective to modify the rate of release of said analgesic from said cured, coated bead.

27. The controlled release layered bead of claim 26, wherein said release-modifying agent is selected from the group consisting of a hydrophilic polymer, a semi-permeable polymer, an erosion-promoting polymer, an agent capable of making microporous lamina, a poreformer and mixtures of any of the foregoing.

28. The controlled release layered bead of claim 21, wherein said analgesic is morphine or a pharmceutically acceptable salt therof.

29. The controlled release layered bead of claim 21, further comprising a second barrier layer overcoated on said controlled release layer.

30. The controlled release layered bead of claim 29, wherein said second barrier layer comprises hydroxypropylmethylcellulose.

31. The controlled release layered bead of claim 30, further comprising an outer coating comprising a loading dose of said analgesic.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc